{"id":46195,"date":"2019-12-04T17:21:45","date_gmt":"2019-12-04T16:21:45","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmj\/?p=46195"},"modified":"2019-12-18T15:52:12","modified_gmt":"2019-12-18T14:52:12","slug":"carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/","title":{"rendered":"Carl Heneghan:\u00a0Australian judge finds mesh manufacturer negligent: here\u2019s why"},"content":{"rendered":"<p><span style=\"font-weight: 400\">On 21 November, a judge in Australia&#8217;s Federal Court, Anna Katzmann, ruled that Ethicon and its subsidiary <\/span><a href=\"https:\/\/www.bmj.com\/content\/367\/bmj.l6659\"><span style=\"font-weight: 400\">Johnson &amp; Johnson had been deceptive, misleading, and negligent<\/span><\/a><span style=\"font-weight: 400\"> in rushing transvaginal products onto the market before conducting proper testing. A further ruling is scheduled in February to consider damages for more than 1350 women involved in the case.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Widely reported in the <\/span><a href=\"https:\/\/www.bmj.com\/content\/367\/bmj.l6659\"><span style=\"font-weight: 400\">media<\/span><\/a><span style=\"font-weight: 400\">, the court ruling is worth further scrutiny, as it raises serious questions about the approval of mesh; inherent problems with the design of mesh; the lack of information and consequently lack of informed consent; and the judge\u2019s damning verdict on the manufacturer\u2019s approach to regulatory approval.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">At 1487 pages, the ruling (you can access it <\/span><a href=\"https:\/\/www.judgments.fedcourt.gov.au\/judgments\/Judgments\/fca\/single\/2019\/2019fca1905\"><span style=\"font-weight: 400\">here<\/span><\/a><span style=\"font-weight: 400\">) takes time to wade through. Given the vital contribution it makes to understanding the problems with mesh, I have tried to summarise some of the critical points. I have numbered the paragraphs (<\/span><span style=\"font-weight: 400\">\u00a7) <\/span><span style=\"font-weight: 400\">in the document if you want to search for the relevant texts.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">The case centred on three women: Kathryn Gill, Diane Dawson, and Ann Sanders, the applicants, who between them received nine mesh devices (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">1) related to the Tension-free Vaginal Tape System (for gaps in the evidence see <\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">3068) for the treatment of stress urinary incontinence, and the Gynecare Gynemesh Prolift (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">3099) and Prosima (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">3106) devices for the treatment of Pelvic Organ Prolapse (POP).<\/span><\/p>\n<p><span style=\"font-weight: 400\">In the case proceedings, &#8220;there was no dispute that all of the complications could be caused by implantation of the Ethicon Devices&#8221; (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">191), and that each was clinically significant. The case primarily focussed on the magnitude of the risks, and whether they had been appropriately disclosed to the applicants (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">195).\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">The credibility of the expert witnesses is covered in <\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">301. Katzman was not impressed with a number of the manufacturer\u2019s witnesses (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">303), who were seen as &#8220;too eager to please the respondents&#8221; (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">305). For example, Prolift erosion rates were reported to be 20.4% in a series of 917 consecutive cases. Professor Alan Lam, who was an author of the report, &#8220;tried to distance himself from this evidence&#8221; (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">271); Judge Katzman found that &#8220;his attempts to resile from the higher erosion rate were quite unconvincing.&#8221; However, among the experts, there was an acceptance that so long as a &#8220;foreign body (such as a mesh implant) is present in the human body, there is likely to be an ongoing or chronic inflammatory response&#8221; (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">353).<\/span><\/p>\n<p><span style=\"font-weight: 400\">Judge Katzman also voiced concerns over the lack of testing of mesh in vaginal tissue in a wide selection of patients before market release (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">340). Mechanically cut mesh was &#8220;particularly problematic,&#8221; as &#8220;it frayed and pieces of polypropylene could break off during implantation&#8221; (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">351).<\/span><\/p>\n<p><span style=\"font-weight: 400\">The size of mesh pores proved contentious: meshes with smaller pores have higher risks of infection<\/span><b>, <\/b><span style=\"font-weight: 400\">cause <\/span><span style=\"font-weight: 400\">less ingrowth of tissue, and lead to more chronic pain and foreign body sensations (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">479).\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">There was &#8220;no place for mesh with pores of less than 1 mm,&#8221; said expert witness Dr Boris Batke (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">481). But pore sizes reduce after implantation: the pores can collapse altogether, and mechanical stresses can further reduce their size (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">500). Under minimal strain, the Prolift mesh arms could curl, with further reduction in pore size (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">510). Even a mild load of one newton has a dramatic impact on pore size. A confidential Ethicon memorandum (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">484) revealed that &#8220;under this loading, the initial pore size of between 3\u20134 mm decreases to values down to 0.3 mm&#8221; (see page 147 for an image of this effect in the UltraPro Mesh). The pore size of the mesh before implantation will therefore not be the pore size of the mesh after implantation (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">516), which the judge described as an &#8220;unacceptable design failure of the Prolift&#8221; (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">519).<\/span><\/p>\n<p><span style=\"font-weight: 400\">Another witness, Professor Klosterhalfen, stated that &#8220;polypropylene mesh products are incompatible with the female pelvis because, while the meshes are flexible, they are not elastic&#8221; (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">611). He also said that &#8220;flexible structures like polypropylene meshes are only able to elongate in one direction but an elastic structure like the vagina can stretch in all directions.&#8221; This mechanical mismatch between the mesh and the pelvis can cause severe damage, including infection, erosion, and chronic pain.<\/span><\/p>\n<p><span style=\"font-weight: 400\">In one of her most damning conclusions (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">4445), Judge Katzman, referring to the certification mark that indicates conformity with health, safety, and environmental protection standards, said that Ethicon was negligent in its evaluations for market approval: &#8220;they did not justify CE marking either before Prolift was taken to market or afterwards. In other words, they were not entitled to apply the CE mark.&#8221; She also provided a stark warning for all manufacturers (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">4440): &#8220;even if the literature route is followed, the manufacturer is obliged to critically review the literature and &#8216;duly&#8217; justify reliance on existing clinical data. As with all the other devices, in the case of Prolift, that obligation was not discharged.&#8221;<\/span><\/p>\n<p><span style=\"font-weight: 400\">Mrs Sanders referred to inadequate consent procedures; &#8220;I assumed, because no one told me otherwise, that it was going to be safe to be inside me for the rest of my life&#8221; (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">4524).<\/span><\/p>\n<p><span style=\"font-weight: 400\">Likewise, Kathryn Gill (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">4462) highlighted that at the time she decided to have mesh inserted, there had been an absence of information on the risks of chronic severe pain and pain on intercourse; the risk of vaginal shortening or narrowing; the fact that an erosion could require multiple operations; that it might be impossible to remove the mesh; and that the mesh might be unsuitable for her because of her psoriasis. She deposed (<\/span><span style=\"font-weight: 400\">\u00a74465) <\/span><span style=\"font-weight: 400\">that she would not have consented to the operation if she had been told of the following matters (reproduced in full):<\/span><\/p>\n<p><span style=\"font-weight: 400\">(1) \u00a0 <\/span> <span style=\"font-weight: 400\">that erosions did not occur only in a small percentage of cases or that they were often difficult to treat and might require multiple operations;<\/span><\/p>\n<p><span style=\"font-weight: 400\">(2) \u00a0 <\/span> <b>the risk of erosion was in the order of 1 in 10 or<\/b><span style=\"font-weight: 400\"> more patients experiencing the problem;<\/span><\/p>\n<p><span style=\"font-weight: 400\">(3) \u00a0 <\/span> <span style=\"font-weight: 400\">there was <\/span><b>a risk of chronic and severe pain<\/b><span style=\"font-weight: 400\"> that might not be able to be treated effectively because the mesh might not be able to be removed;<\/span><\/p>\n<p><span style=\"font-weight: 400\">(4) \u00a0 <\/span> <span style=\"font-weight: 400\">there was a<\/span><b> risk of chronic pain with intercourse<\/b><span style=\"font-weight: 400\"> which might not be able to be remedied because the mesh might not be able to be removed;<\/span><\/p>\n<p><span style=\"font-weight: 400\">(5) \u00a0 <\/span> <span style=\"font-weight: 400\">the mesh <\/span><b>was unsuitable for younger women<\/b><span style=\"font-weight: 400\"> like her who wished to remain sexually and physically active;<\/span><\/p>\n<p><span style=\"font-weight: 400\">(6) \u00a0 <\/span> <span style=\"font-weight: 400\">the mesh was unsuitable for patients with an <\/span><b>autoimmune disease like psoriasis;<\/b><\/p>\n<p><span style=\"font-weight: 400\">(7) \u00a0 <\/span> <span style=\"font-weight: 400\">there was a risk of recurrence of the prolapse which would be more difficult to treat because of the presence of the mesh;<\/span><\/p>\n<p><span style=\"font-weight: 400\">(8) \u00a0 <\/span> <span style=\"font-weight: 400\">there were <\/span><b>risks of vaginal narrowing and shortening<\/b><span style=\"font-weight: 400\">;<\/span><\/p>\n<p><span style=\"font-weight: 400\">(9) \u00a0 <\/span> <span style=\"font-weight: 400\">there was a risk of contraction of the mesh, which could cause chronic pain and pain with intercourse, and which might be difficult to treat because the mesh might be unable to be removed.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400\">There are important issues that I haven\u2019t covered, which others might want to discuss: <\/span><span style=\"font-weight: 400\">the role of key opinion leaders, such as the TVM group (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">148); the placement of mesh <\/span><span style=\"font-weight: 400\">(<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">180), the mechanism of mesh erosion (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">218), pain (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">229), the role of tension (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">263), and the significance of the immune response and those with preexisting immune conditions (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">278).<\/span><\/p>\n<p><span style=\"font-weight: 400\">You can also read about problems with biocompatibility and lack of understanding of what constitutes an &#8220;appropriate host response&#8221; (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">330); a host of issues with the instructions for use (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">2836); and misclassification of the risks as rare (<\/span><span style=\"font-weight: 400\">\u00a7<\/span><span style=\"font-weight: 400\">4491).<\/span><\/p>\n<p><span style=\"font-weight: 400\">Finally, achieving only the minimum requirements for regulatory approval of devices will be judged harshly in a court of law. Johnson &amp; Johnson, have until the 20th of December to appeal the decision.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">This judgment should make regulators, policymakers, health professionals, and manufacturers urgently rethink the methods for approving transvaginal mesh products.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">To all those involved with mesh or affected by mesh, the judgment makes for sobering reading.\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><em><strong><a href=\"https:\/\/blogs.bmj.com\/bmj\/files\/2019\/06\/ebm_logo_large.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-44747\" src=\"https:\/\/blogs.bmj.com\/bmj\/files\/2019\/06\/ebm_logo_large-300x194.jpg\" alt=\"\" width=\"300\" height=\"194\" srcset=\"https:\/\/blogs.bmj.com\/bmj\/files\/2019\/06\/ebm_logo_large-300x194.jpg 300w, https:\/\/blogs.bmj.com\/bmj\/files\/2019\/06\/ebm_logo_large.jpg 540w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a>BMJ Evidence-Based Medicine<\/strong>\u00a0<\/em>publishes\u00a0original\u00a0evidence based research, insights and opinions on what matters for health care. (<a href=\"https:\/\/ebm.bmj.com\/pages\/authors\/?gclid=Cj0KCQiA3IPgBRCAARIsABb-iGJ_GVoX8r6tJc_X9p31vzRnTo_S2Z4U1AiXX4UgblkOQ5Un4q6-Vm0aAmewEALw_wcB\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/ebm.bmj.com\/pages\/authors\/?gclid%3DCj0KCQiA3IPgBRCAARIsABb-iGJ_GVoX8r6tJc_X9p31vzRnTo_S2Z4U1AiXX4UgblkOQ5Un4q6-Vm0aAmewEALw_wcB&amp;source=gmail&amp;ust=1559659893257000&amp;usg=AFQjCNEguf6V8-Scr2cK6LpTbtAENShhyw\">Instructions for authors<\/a>)<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em><b><a href=\"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/03\/carl_heneghan2.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-38834\" src=\"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/03\/carl_heneghan2.jpg\" alt=\"\" width=\"160\" height=\"160\" srcset=\"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/03\/carl_heneghan2.jpg 160w, https:\/\/blogs.bmj.com\/bmj\/files\/2017\/03\/carl_heneghan2-150x150.jpg 150w\" sizes=\"auto, (max-width: 160px) 100vw, 160px\" \/><\/a><\/b><\/em><\/p>\n<p><i><span style=\"font-weight: 400\"><strong>Carl Heneghan<\/strong> is the editor in Chief<\/span><\/i><a href=\"https:\/\/ebm.bmj.com\/content\/22\/6\/202\"> <i><span style=\"font-weight: 400\">BMJ EBM<\/span><\/i><\/a><i><span style=\"font-weight: 400\">, Professor of EBM, University of Oxford and will be speaking at EBM Live, <\/span><\/i><a href=\"https:\/\/ebmlive.org\/wp-content\/uploads\/sites\/3\/2019\/10\/Getting-Better-with-Evidence-.pdf\"><i><span style=\"font-weight: 400\">Getting Better with Evidence<\/span><\/i><\/a><i><span style=\"font-weight: 400\">, on the 10th December in New Zealand on the implications of the mesh judgment.\u00a0<\/span><\/i><\/p>\n<p><b>Acknowledgement:<\/b><span style=\"font-weight: 400\">\u00a0 I would like to thank Jeff Aronson for helpful comments and edits.<\/span><\/p>\n<p><b><i>Competing interests:<\/i><\/b><i><span style=\"font-weight: 400\"> CH has received expenses and fees for his media work. He holds grant funding from the NIHR, the NIHR School of Primary Care Research and the NIHR Oxford BRC. He has received financial remuneration from an asbestos case and given free legal advice on mesh cases, and received income from the publication of a series of toolkit books published by Blackwells. On occasion, he receives expenses for teaching EBM and is also paid for his GP work in NHS out of hours. He is Editor in Chief of BMJ Evidence-Based Medicine, clinical advisor to the APPG on Surgical Mesh and an NIHR Senior Investigator. CH is also Director of CEBM and Programs in EBHC CEBM jointly runs the EvidenceLive Conference with the BMJ and the Overdiagnosis Conference with some international partners based on a non-profit model.<\/span><\/i><\/p>\n<p>&nbsp;<\/p>\n<p><b>FEDERAL COURT OF AUSTRALIA<\/b><\/p>\n<p><b>Gill v Ethicon S\u00e0rl (No 5) [2019] FCA 1905<\/b><\/p>\n<p><a href=\"https:\/\/www.judgments.fedcourt.gov.au\/judgments\/Judgments\/fca\/single\/2019\/2019fca1905\"><span style=\"font-weight: 400\">https:\/\/www.judgments.fedcourt.gov.au\/judgments\/Judgments\/fca\/single\/2019\/2019fca1905<\/span><\/a><\/p>\n<p><a href=\"https:\/\/www.judgments.fedcourt.gov.au\/__data\/assets\/word_doc\/0011\/577721\/2019FCA1905.docx?v=0.1.5\"><span style=\"font-weight: 400\">Original Word Document (4.4 MB)<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>On 21 November, a judge in Australia&#8217;s Federal Court, Anna Katzmann, ruled that Ethicon and its subsidiary Johnson &amp; Johnson had been deceptive, misleading, and negligent in rushing transvaginal products [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/\">More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":43096,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18908],"tags":[],"class_list":["post-46195","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-carl-heneghan"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Carl Heneghan:\u00a0Australian judge finds mesh manufacturer negligent: here\u2019s why - The BMJ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Carl Heneghan:\u00a0Australian judge finds mesh manufacturer negligent: here\u2019s why - The BMJ\" \/>\n<meta property=\"og:description\" content=\"On 21 November, a judge in Australia&#8217;s Federal Court, Anna Katzmann, ruled that Ethicon and its subsidiary Johnson &amp; Johnson had been deceptive, misleading, and negligent in rushing transvaginal products [...]More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/\" \/>\n<meta property=\"og:site_name\" content=\"The BMJ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bmjdotcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-12-04T16:21:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-12-18T14:52:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/vaginal_mesh.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"540\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BMJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:site\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BMJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/\"},\"author\":{\"name\":\"BMJ\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\"},\"headline\":\"Carl Heneghan:\u00a0Australian judge finds mesh manufacturer negligent: here\u2019s why\",\"datePublished\":\"2019-12-04T16:21:45+00:00\",\"dateModified\":\"2019-12-18T14:52:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/\"},\"wordCount\":1498,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/09\\\/vaginal_mesh.jpg\",\"articleSection\":[\"Carl Heneghan\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/\",\"name\":\"Carl Heneghan:\u00a0Australian judge finds mesh manufacturer negligent: here\u2019s why - The BMJ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/09\\\/vaginal_mesh.jpg\",\"datePublished\":\"2019-12-04T16:21:45+00:00\",\"dateModified\":\"2019-12-18T14:52:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/09\\\/vaginal_mesh.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/09\\\/vaginal_mesh.jpg\",\"width\":540,\"height\":350},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2019\\\/12\\\/04\\\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Carl Heneghan:\u00a0Australian judge finds mesh manufacturer negligent: here\u2019s why\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"name\":\"The BMJ\",\"description\":\"Helping doctors make better decisions.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\",\"name\":\"The BMJ\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"width\":852,\"height\":568,\"caption\":\"The BMJ\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bmjdotcom\\\/\",\"https:\\\/\\\/x.com\\\/bmj_latest\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\",\"name\":\"BMJ\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"caption\":\"BMJ\"},\"sameAs\":[\"https:\\\/\\\/blogs.bmj.com\\\/\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Carl Heneghan:\u00a0Australian judge finds mesh manufacturer negligent: here\u2019s why - The BMJ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/","og_locale":"en_US","og_type":"article","og_title":"Carl Heneghan:\u00a0Australian judge finds mesh manufacturer negligent: here\u2019s why - The BMJ","og_description":"On 21 November, a judge in Australia&#8217;s Federal Court, Anna Katzmann, ruled that Ethicon and its subsidiary Johnson &amp; Johnson had been deceptive, misleading, and negligent in rushing transvaginal products [...]More...","og_url":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/","og_site_name":"The BMJ","article_publisher":"https:\/\/www.facebook.com\/bmjdotcom\/","article_published_time":"2019-12-04T16:21:45+00:00","article_modified_time":"2019-12-18T14:52:12+00:00","og_image":[{"width":540,"height":350,"url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/vaginal_mesh.jpg","type":"image\/jpeg"}],"author":"BMJ","twitter_card":"summary_large_image","twitter_creator":"@bmj_latest","twitter_site":"@bmj_latest","twitter_misc":{"Written by":"BMJ","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/"},"author":{"name":"BMJ","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe"},"headline":"Carl Heneghan:\u00a0Australian judge finds mesh manufacturer negligent: here\u2019s why","datePublished":"2019-12-04T16:21:45+00:00","dateModified":"2019-12-18T14:52:12+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/"},"wordCount":1498,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/vaginal_mesh.jpg","articleSection":["Carl Heneghan"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/","url":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/","name":"Carl Heneghan:\u00a0Australian judge finds mesh manufacturer negligent: here\u2019s why - The BMJ","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/vaginal_mesh.jpg","datePublished":"2019-12-04T16:21:45+00:00","dateModified":"2019-12-18T14:52:12+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/vaginal_mesh.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/09\/vaginal_mesh.jpg","width":540,"height":350},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmj\/2019\/12\/04\/carl-heneghan-australian-judge-finds-mesh-manufacturer-negligent-heres-why\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmj\/"},{"@type":"ListItem","position":2,"name":"Carl Heneghan:\u00a0Australian judge finds mesh manufacturer negligent: here\u2019s why"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmj\/#website","url":"https:\/\/blogs.bmj.com\/bmj\/","name":"The BMJ","description":"Helping doctors make better decisions.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmj\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmj\/#organization","name":"The BMJ","url":"https:\/\/blogs.bmj.com\/bmj\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","width":852,"height":568,"caption":"The BMJ"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bmjdotcom\/","https:\/\/x.com\/bmj_latest"]},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe","name":"BMJ","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","caption":"BMJ"},"sameAs":["https:\/\/blogs.bmj.com\/"],"url":"https:\/\/blogs.bmj.com\/bmj\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/46195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=46195"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/46195\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media\/43096"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=46195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=46195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=46195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}